167 related articles for article (PubMed ID: 11021735)
21. Pharmacokinetics of DA-125, a new anthracycline, after intravenous administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats.
Yoon EJ; Shim HJ; Lee JJ; Lee SD; Kim WB; Yang J; Lee MG
Drug Metab Dispos; 1997 Jan; 25(1):66-74. PubMed ID: 9010632
[TBL] [Abstract][Full Text] [Related]
22. Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Drug Metab Dispos; 2011 Aug; 39(8):1440-50. PubMed ID: 21571947
[TBL] [Abstract][Full Text] [Related]
23. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
[TBL] [Abstract][Full Text] [Related]
24. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
25. Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats.
Schjøtt J; Gjerde J; Kisanga ER; Lien EA
Basic Clin Pharmacol Toxicol; 2006 Feb; 98(2):231-4. PubMed ID: 16445601
[No Abstract] [Full Text] [Related]
26. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
[TBL] [Abstract][Full Text] [Related]
27. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
28. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
El-Shitany NA; El-Haggar S; El-desoky K
Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
[TBL] [Abstract][Full Text] [Related]
29. High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity.
Mitra MS; Donthamsetty S; White B; Mehendale HM
Toxicol Appl Pharmacol; 2008 Sep; 231(3):413-22. PubMed ID: 18674790
[TBL] [Abstract][Full Text] [Related]
30. The effects of lipiodol and cyclosporin A on the hepatobiliary disposition of doxorubicin in pigs.
Dubbelboer IR; Lilienberg E; Hedeland M; Bondesson U; Piquette-Miller M; Sjögren E; Lennernäs H
Mol Pharm; 2014 Apr; 11(4):1301-13. PubMed ID: 24558959
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
32. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
33. PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential.
Della Torre P; Podestà A; Imondi AR; Moneta D; Sammartini U; Arrigoni C; Terron A; Brughera M
Cancer Chemother Pharmacol; 2001 Apr; 47(4):355-60. PubMed ID: 11345653
[TBL] [Abstract][Full Text] [Related]
34. [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients].
Wihlm J; Limacher JM; Levêque D; Duclos B; Dufour P; Bergerat JP; Methlin G
Bull Cancer; 1997 Jun; 84(6):603-8. PubMed ID: 9295863
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
Maniez-Devos DM; Baurain R; Lesne M; Trouet A
J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the pharmacokinetics and cardiotoxicity of doxorubicin in rat receiving nilotinib.
Zhou ZY; Wan LL; Yang QJ; Han YL; Li Y; Yu Q; Guo C; Li X
Toxicol Appl Pharmacol; 2013 Oct; 272(1):238-44. PubMed ID: 23770382
[TBL] [Abstract][Full Text] [Related]
38. Minor effects of the citrus flavonoids naringin, naringenin and quercetin, on the pharmacokinetics of doxorubicin in rats.
Park HS; Oh JH; Lee Jh; Lee YJ
Pharmazie; 2011 Jun; 66(6):424-9. PubMed ID: 21699081
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity.
Yilmaz S; Atessahin A; Sahna E; Karahan I; Ozer S
Toxicology; 2006 Feb; 218(2-3):164-71. PubMed ID: 16325981
[TBL] [Abstract][Full Text] [Related]
40. Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1.
Olson LE; Bedja D; Alvey SJ; Cardounel AJ; Gabrielson KL; Reeves RH
Cancer Res; 2003 Oct; 63(20):6602-6. PubMed ID: 14583452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]